Drug recall · September 27, 2023
Cequa (cyclosporine ophthalmic solution) 0.09% recall
Why: Subpotent: Out of Specification result observed for low assay
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96
- Lots / codes
Lot# 10026, Lot 10027, Exp. 09/2023.
- Quantity
- 69,707 cartons
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- Nationwide wide in the USA
- Initiated
- September 7, 2023 · Voluntary: Firm initiated
- Classified
- September 20, 2023
- Reported
- September 27, 2023
- Ended
- February 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cequa
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.